Difficulty: Medium
Average Score: 78%
Practice
Which of the following drugs used in Parkinson's disease is a peripherally acting dopa decarboxylase inhibitor?
Correct answer
D
Rationale
Carbidopa is a peripherally acting dopa decarboxylase inhibitor that prevents the breakdown of levodopa in the periphery allowing more to reach the brain.